Studies have revealed that plasma level of HULC and NEAT1 are markedly elevated in HCC patients [144, 145], serving as significant predictors of HCC tumor growth and metastasis, which hold promise as non-invasive biomarkers for diagnosing hepatoma, and their diagnostic accuracy may be enhanced when combined with AFP [145–147]. The gene discussed is HULC; the disease is hepatocellular carcinoma.